BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 19335370)

  • 41. Microbiology and drug resistance mechanisms of fully resistant pathogens.
    Walsh FM; Amyes SG
    Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Staphylococcus aureus: a community pathogen.
    Miller LG; Kaplan SL
    Infect Dis Clin North Am; 2009 Mar; 23(1):35-52. PubMed ID: 19135915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales.
    Austin DJ; Anderson RM
    J Infect Dis; 1999 Apr; 179(4):883-91. PubMed ID: 10068583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Community acquired infections with methicillin resistant strains of Staphylococcus aureus: report of five cases].
    Noriega LM; González P; Hormazábal JC; Pinto C; Canals M; Munita JM; Thompson L; Marcotti A; Pérez J; Ibáñez D; Araya P; Canals C; Vial P
    Rev Med Chil; 2008 Jul; 136(7):885-91. PubMed ID: 18949165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enterococci resistant to glycopeptides].
    Cattoir V; Leclercq R
    Med Sci (Paris); 2010 Nov; 26(11):936-42. PubMed ID: 21106175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vancomycin-resistant Enterococci. Prevalence and risk factors for fecal carriage in patients at tertiary care hospitals.
    El-Amin NM; Faidah HS
    Saudi Med J; 2011 Sep; 32(9):966-7. PubMed ID: 21894365
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of glycopeptide resistant enterococci in hospitalized patients and in the community in Calabria (Italy)].
    Nobile CG; Ceravolo C; Rizzo L; Bianco A
    Ann Ig; 2003; 15(5):515-20. PubMed ID: 14969304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 55. Vancomycin resistant Enterococci in a tertiary care hospital in Mumbai.
    De A; Bindlish A; Kumar S; Mathur M
    Indian J Med Microbiol; 2009; 27(4):375-6. PubMed ID: 19736416
    [No Abstract]   [Full Text] [Related]  

  • 56. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen.
    Top J; Willems R; Bonten M
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):297-308. PubMed ID: 18279340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital.
    Valdezate S; Labayru C; Navarro A; Mantecón MA; Ortega M; Coque TM; García M; Saéz-Nieto JA
    J Antimicrob Chemother; 2009 Jan; 63(1):17-20. PubMed ID: 19001448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes.
    Tong SY; Bishop EJ; Lilliebridge RA; Cheng AC; Spasova-Penkova Z; Holt DC; Giffard PM; McDonald MI; Currie BJ; Boutlis CS
    J Infect Dis; 2009 May; 199(10):1461-70. PubMed ID: 19392622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
    Recinos G; Inaba K; Dubose J; Barmparas G; Teixeira PG; Talving P; Belzberg H; Demetriades D
    Am Surg; 2009 Nov; 75(11):1077-80. PubMed ID: 19927509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.